Abstract
Upper airway imaging provides important knowledge about the pathogenesis and treatment of obstructive sleep apnea (OSA). It allows for the characterization of the size of the upper airway, the surrounding pharyngeal soft tissue, and craniofacial structures. Upper airway imaging can be static or dynamic and can be performed during sleep. It can also provide key information about the anatomic changes with CPAP (continuous positive airway pressure), oral appliances, weight loss, and upper airway surgery. Such information can provide insights into the mechanism of action of different treatments for sleep apnea.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
Upper airway imaging provides important knowledge about the pathogenesis and treatment of obstructive sleep apnea (OSA). It allows for the characterization of the size of the upper airway, the surrounding pharyngeal soft tissue, and craniofacial structures. Upper airway imaging can be static or dynamic and can be performed during sleep. It can also provide key information about the anatomic changes with CPAP (continuous positive airway pressure), oral appliances, weight loss, and upper airway surgery. Such information can provide insights into the mechanism of action of different treatments for sleep apnea.
1 Different Imaging Modalities to Examine the Upper Airway
Many different imaging modalities can evaluate the upper airway lumen, pharyngeal soft tissues, and craniofacial structure. These include the following: (1) cephalometrics can examine a two-dimensional skeleton; (2) nasopharyngoscopy can examine pharyngeal lumen awake and asleep (drug-induced sleep endoscopy); (3) ultrasound can examine pharyngeal anatomy without radiation; (4) PET (positron emission tomography) in conjunction with CT (computed tomography) or MRI (magnetic resonance imaging) can examine tongue metabolic function and upper airway inflammation; (5) CT can examine static and dynamic pharyngeal anatomy; and (6) MRI can examine static (volumes of the upper airway soft tissues including tongue fat), dynamic upper anatomy and state-dependent imaging. In this chapter, we will discuss each of these imaging modalities in more detail and how they provide insights into the diagnosis and management of patients with OSA.
2 Insights into the Pathogenesis of OSA with Static Upper Airway Imaging
There are a number of different imaging modalities that have provided important insights into the pathogenesis of OSA. Cephalometrics (Fig. 1) has been utilized in many studies to study static craniofacial anatomy [1, 2]. The lateral cephalogram is a standardized lateral view radiograph of the head and neck that provides information on bony and soft tissue structures. Cephalometric imaging can determine if a patient is retrognathic, but it is only a two-dimensional representation examining anterior-posterior anatomy and does not provide information on lateral structures. CT (Figs. 2, 3, 4, and 5) and MRI (Figs. 6, 7, and 8) scanning provides high resolution 3-D representation of the upper airway lumen, soft tissues, and craniofacial anatomy [3]. MRI in particular has provided novel insights into the pathogenesis of OSA. An MRI study [4] has shown that upper airway volume is smallest in the retropalatal region and smaller in apneics than controls. That study [4] also showed that the volume of the soft tissue structures surrounding the upper airway is enlarged in patients with sleep apnea and that this enlargement is a significant risk factor for sleep apnea. In particular, after covariate adjustments, the volume of the tongue, lateral pharyngeal walls, and total soft tissue was significantly larger in patients with sleep apnea than in normal subjects. These data also demonstrated that the larger the volume of the tongue, lateral pharyngeal walls, and total soft tissue, the greater the risk of developing sleep apnea.
One of the reasons tongue size is greater in patients with sleep apnea is related to increased tongue fat (Figs. 9, 10, and 11) and may explain the relationship between obesity and sleep apnea. An MRI study [5] using Dixon imaging (a method to specifically image fat) to examine tongue fat demonstrated: (1) apneics have greater tongue volumes and more fat within the tongue compared to control subjects, after adjustments for age, BMI, gender, and race; (2) in both apneics and controls, more fat was present in the tongue than in a control upper airway muscle (masseter); (3) tongue fat percentage was greater in the retroglossal region compared to the retropalatal region; and (4) tongue fat volume correlated with BMI (body mass index) and AHI (apnea–hypopnea index).
MRI can also examine craniofacial dimensions (Figs. 12, 13, and 14). In a case-control study [6] using three-dimensional magnetic resonance imaging cephalometry in 55 apneics and 55 controls matched for age, sex, and race, the following was found: (1) a 1-SD increase in mandibular length and depth were associated with decreased risk of sleep apnea in men but not in women and (2) increases in hyoid-to-nasion and supramentale-to-hyoid distances were associated with increased risk of OSA in both men and women. In this study [6], a smaller and shallower mandible was an independent risk factor for OSA in males, but not females, and the size of the mandible (length and depth) was a much more important risk factor for OSA than maxillary measures or angular measurements [SNA (angle between sella, nasion, and subspinale point A) and SNB (angle between sella, nasion, and supramentale point B)].
Ultrasound has also been shown to have the capability of measuring tongue size (Fig. 15) and tongue fat (Fig. 16). Studies have used submental ultrasound to characterize the tongue in OSA, showing that increased tongue width and tongue thickness are associated with severe OSA [7,8,9,10]. Tongue fat [11] can also be determined with ultrasound. In this study, echo intensity of the tongue base strongly correlated to the fat percentage for both the posterior tongue and the entire tongue measured with MRI. Larger tongue fat percentages and higher echo intensity were associated with a higher apnea–hypopnea index, after adjustments for age, body mass index, sex, and race. Thus, ultrasound could be used as an alternative method to quantify tongue fat since this modality is faster, cheaper, and more easily accessible than MRI.
3 Insights into the Pathogenesis of OSA with Dynamic Upper Airway Imaging
Dynamic upper airway imaging can be performed with cine CT (Fig. 17) or cine MRI (Fig. 18, 19, and 20). Unlike static imaging, dynamic magnetic resonance imaging provides the capability of studying upper airway respiratory-related changes. A study [12] with dynamic MRI has shown: (1) airway area in the retropalatal region was significantly smaller in obese subjects with apnea compared with obese control subjects, controlling for sex, age, BMI, and race; (2) airway narrowing in apneics was observed in both lateral and AP dimensions in the retropalatal region; and (3) there were strong correlations between AHI (apnea–hypopnea index) and many of the dynamic airway measures in both retropalatal and retroglossal regions.
The primary finding of this study [12] was that the retropalatal and not the retroglossal region of the upper airway was significantly narrower in obese subjects with apnea than in obese control subjects during respiration. These findings provide further evidence that retropalatal airway narrowing rather than retroglossal airway narrowing plays an important role in the pathogenesis of obstructive sleep apnea in obese subjects.
Another modality to examine dynamic changes to the pharyngeal lumen is with a nasal endoscope and drug-induced sleep endoscopy (DISE). DISE is typically used by otorhinolaryngologists to determine the site of airway collapse before undergoing upper airway surgery and it is used before hypoglossal nerve stimulation to ensure the patient does not have concentric collapse (a contraindication to hypoglossal nerve stimulation). DISE is typically scored [13] via a VOTE (velum, oropharynx, tongue base, and epiglottis) classification but the airway changes can be quantified (Figs. 21 and 22) [14].
4 Insights into the Metabolic Function in OSA Patients with PET Imaging
PET with or without CT or MRI scanning (Figs. 23 and 24) has been utilized to examine metabolic uptake of the tongue. In one study [15] using [18F]-2-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography imaging, there was significantly reduced glucose uptake in the genioglossus (primary dilator muscle of the upper airway) of patients with sleep apnea in comparison with obese normal subjects. Specifically, after adjusting for confounders including age, BMI, sex, and race: (1) FDG uptake was reduced in the genioglossus of patients with OSA compared with control subjects; (2) the results remained unchanged after adjusting for tongue fat; and (3) there were no differences in FDG uptake in other upper airway muscles (masseter, pterygoid) between patients with sleep apnea and control subjects. These data indicate that there are selective alterations in glucose metabolism within the primary soft tissue structures of the upper airway in patients with OSA. These alterations may be the result of repeated apneas and could directly contribute to OSA. PET imaging offers a new paradigm for understanding the muscle properties of the upper airway soft tissue structures.
PET MRI has also been utilized to examine inflammation in the mucosa of the upper airway [16]. Repetitive upper airway collapse during apneic events can result in upper airway inflammation. This inflammation measured by PET/MRI has been shown [17] to be reduced with CPAP therapy in adults with OSA. Adult OSA patients underwent [18F]-fluoro-2-deoxy-D-glucose (FDG)-PET/MRI of the neck before and after 3 months of using CPAP [17].
5 Insights into the Pathogenesis of OSA with State-Dependent Upper Airway Imaging
Upper airway imaging during wakefulness has provided key insights about the risk factors and pathogenesis of sleep apnea. But the changes that occur to the upper airway during sleep (Figs. 25, 26, and 27) are fundamental to understanding the site of collapse and biomechanical changes of the pharyngeal structures during apnea or hypopnea. In a study [18] examining state-dependent changes to the upper airway in normal subjects, the volume of the retropalatal airway was reduced by 19%. The volume of the retroglossal airway was not reduced during sleep, suggesting that the RP region may be more likely to narrow during sleep. The mean minimal cross-sectional airway area in the retropalatal region was reduced by 228% but only by 22% in the retroglossal region during sleep as compared with values during wakefulness. Reduction in the retropalatal airway area during sleep resulted from posterior movement of the soft palate, medial movement of the lateral pharyngeal walls, and posterior movement of the tongue. This study [18] used spin echo imaging over 3–4 minutes to examine state-related changes to the upper airway but newer imaging techniques [19,20,21,22,23] examine dynamic state-related changes to the upper airway.
6 Imaging Studies Examining OSA Treatments
There are multiple effective treatments for sleep apnea including CPAP, oral appliance, weight loss, ablative upper airway surgery, and hypoglossal nerve stimulation. Upper imaging can provide insights into the mechanism of action of each of these therapeutic interventions. We will examine studies before and after these interventions in the following sections.
6.1 Imaging Studies Examining Mechanism of Action of CPAP
CPAP is the treatment of choice for patients with sleep apnea. CPAP has been shown with imaging studies [24] to increase airway caliber threefold (Figs. 28, 29, 30, and 31) in both retropalatal and retroglossal regions. The increase in airway caliber (Figs. 28, 29, 30, and 31) is primarily in the lateral dimension secondary to reductions in the thickness of the lateral pharyngeal walls. Airway caliber (Figs. 28, 29, 30, and 31) with CPAP does not increase as much in the anterior-posterior dimension as compared to the lateral dimension.
6.2 Imaging Studies Examining Mechanism of Action of Weight Loss
Weight loss has been shown to clinically improve sleep apnea. A study [25] using MR Dixon MR imaging (Figs. 32 and 33) has shown that weight loss decreases tongue fat and that the reduction in tongue fat is the primary mediator of the improvement in AHI (apnea–hypopnea index). Specifically, this study showed: (1) weight loss was significantly associated with reductions in tongue fat, pterygoid, and total lateral wall volumes; (2) strong correlations were observed between reductions in AHI and reductions in tongue fat volume; and (3) reduction in tongue fat volume was the primary upper airway mediator of the relationship between weight loss and AHI. These findings suggest that reductions in tongue fat may be a unique therapeutic target for patients with obesity and sleep apnea.
6.3 Imaging Studies Examining Mechanism of Action of Oral Appliances
Oral appliances have also been shown to be an effective treatment [26, 27] for OSA. There are many different oral appliances for patients with sleep apnea and we do not know the optimal oral appliance (it may be patient dependent). Both vertical bite opening and mandibular advancement may be important in the improvement of OSA with oral appliances. Upper airway MRI (Figs. 34 and 35) can provide data on the biomechanical mechanism of action of oral appliances. In an MRI study [28], treatment with an oral appliance resulted in the following: (1) reduced the AHI from 27.0 to 12.2 events/hour; (2) increased the total airway volume predominantly because of an increase in the volume in the retropalatal region; (3) an increase in the lower anterior facial height; (4) a reduction in the distance between the hyoid and the posterior nasal spine; (5) lateral displacement of the parapharyngeal fat pads; and (6) anterior movement of the tongue base muscles. Imaging studies examining the mechanism of action of the oral appliance will be important for determining the optimal oral appliance.
6.4 Imaging Studies Examining Mechanism of Action of Ablative Upper Airway Surgery
If CPAP or oral appliances are either ineffective or not tolerated, patients may consider ablative upper airway surgery to treat their sleep apnea. The most common upper airway surgery in adults is a UPPP (uvulopalatopharyngoplasty), but other options include maxillomandibular advancement and base of tongue surgery. Transoral robotic surgery (TORS) has recently become a new surgical approach [29,30,31] for the treatment of OSA because it allows for better access to the base of the tongue compared to conventional procedures. Volumetric MRI [32] can be an important tool (Figs. 36 and 37) to understand the postsurgical anatomic changes and reasons for success/nonsuccess in all sleep surgeries (including TORS). Accordingly, upper airway MRIs [32] were performed pre- and postoperatively in apneics undergoing TORS (surgery included bilateral posterior hemiglossectomy with limited pharyngectomy and uvulopalatopharyngoplasty). Pre- to postoperative changes from this study [32] included: (1) a 19.4% increase in total airway volume; (2) decreases in the soft palate and tongue volumes by 18.3% and 5.8%, respectively; (3) decreases in retropalatal and total lateral wall volumes by 49.8% and 17.9%, respectively; (4) no volumetric changes in other structures; and (5) reductions in retropalatal lateral wall volume correlated with decreased AHI. Such studies indicate that volumetric MRI is an important tool to understand the postsurgical anatomic changes and reasons for success in all types of sleep surgery (including TORS).
6.5 Imaging Studies Examining Mechanism of Action of Hypoglossal Nerve Stimulation
Recently hypoglossal nerve stimulation has been utilized for OSA treatment [33]. This surgery has a distinct advantage over other surgeries for sleep apnea since it is reversible and effective. We can understand the mechanism of action of hypoglossal nerve stimulation (Figs. 38, 39, and 40) with CT scanning [34]. A CT imaging study [34] with hypoglossal nerve stimulation during wakefulness was used to examine differences in upper airway caliber, the volume of the upper airway soft tissue structures, craniofacial relationships, and centroid tongue and soft palate position in responders and nonresponders. These data indicated responders had a smaller baseline soft palate volume compared to nonresponders. During stimulation, responders compared to nonresponders had: (1) a larger increase in the retroglossal airway size; (2) greater shortening of the mandible-hyoid distance (hyoid movement toward the mandible); and (3) increased anterior displacement of the tongue (based on the tongue centroids). Such data indicate that we can understand the mechanism of action of hypoglossal nerve stimulation with CT scanning.
References
Neelapu BC, Kharbanda OP, Sardana HK, Balachandran R, Sardana V, Kapoor P, et al. Craniofacial and upper airway morphology in adult obstructive sleep apnea patients: A systematic review and meta-analysis of cephalometric studies. Sleep Med Rev. 2017;31(1532–2955 (Electronic)):79–90.
Agha B, Johal A. Facial phenotype in obstructive sleep apnea-hypopnea syndrome: a systematic review and meta-analysis. J Sleep Res. 2017;26(2):122–31.
Chen H, Aarab G, de Ruiter MHT, de Lange J, Lobbezoo F, van der Stelt PF. Three-dimensional imaging of the upper airway anatomy in obstructive sleep apnea: a systematic review. Sleep Med. 2016;21:19–27.
Schwab R, Pasirstein M, Pierson R, Mackley A, Hachadoorian R, Arens R, et al. Identification of upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging. Am J Respir Crit Care Med. 2003;168(5):522–30.
Kim AM, Keenan BT, Jackson N, Chan EL, Staley B, Poptani H, et al. Tongue fat and its relationship to obstructive sleep apnea. Sleep. 2014;37(10):1639–48.
Chi L, Comyn FL, Mitra N, Reilly MP, Wan F, Maislin G, et al. Identification of craniofacial risk factors for obstructive sleep apnoea using three-dimensional MRI. Eur Respir J. 2011;38(2):348–58.
Lahav Y, Rosenzweig E, Heyman Z, Doljansky J, Green A, Dagan Y. Tongue base ultrasound: a diagnostic tool for predicting obstructive sleep apnea. Ann Otol Rhinol Laryngol. 2009;118(3):179–84.
Shu CC, Lee P, Lin JW, Huang CT, Chang YC, Wang HC. The use of sub-mental ultrasonography for identifying patients with severe obstructive sleep apnea. PLoS One. 2013;8(5):e62848.
Liao LJ, Cho TY, Cheng PW, Wang CT, Lo WC, et al. Submental ultrasonography in diagnosing severe obstructive sleep apnea syndrome. J Med Ultrasound. 2016;24(3):107–11.
Bilici S, Engin A, Ozguz Y, Onerci CO, Gorkem YA, Hande YA. Submental ultrasonographic parameters among patients with obstructive sleep apnea. Otolaryngol Head Neck Surg. 2017;156(3):559–66.
Yu JL, Wiemken A, Schultz SM, Keenan BT, Sehgal CM, Schwab RJ. A comparison of ultrasound echo intensity to magnetic resonance imaging as a metric for tongue fat evaluation. Sleep. 2022;45(2):zsab295.
Feng Y, Keenan BT, Wang S, Leinwand S, Wiemken A, Pack AI, et al. Dynamic upper airway in obese apneics and obese controls. Am J Respir Crit Care Med. 2018;198(11):1435–43.
Kezirian EJ, Hohenhorst W, De Vries N. Drug-induced sleep endoscopy: the VOTE classification. Eur Arch Otorhinolaryngol. 2011;268(8):1233–6.
Borek R, Schwab RJ, Thaler E, Kim C, Jackson N, Mandel JE. Quantitative airway analysis during drug-induced sleep endoscopy for evaluation of sleep apnea. Laryngoscope. 2012;122(11):2592–9.
Kim AM, Keenan BT, Jackson N, Chan EL, Staley B, Torigian DA, et al. Metabolic activity of the tongue in obstructive sleep apnea: a novel application of FDG positron emission topography imaging. Am J Respir Criti Care Med. 2014;189(11):1416–25.
Cohen O, John MM, Kaufman AE, Kundel V, Burschtin O, Khan S, et al. Novel non-invasive assessment of upper airway inflammation in obstructive sleep apnea using positron emission tomography/magnetic resonance imaging. Sleep Breath. 2022;26(3):1087–96.
Cohen O, Kaufman AE, Choi H, Khan S, Robson PM, Suárez-Fariñas M, et al. Pharyngeal inflammation on positron emission tomography/magnetic resonance imaging before and after obstructive sleep apnea treatment. Ann Am Thorac Soc. 2023;20(4):574–83. Dec 7; Epub ahead of print
Trudo FJ, Gefter WB, Welch KC, Gupta KB, Maislin G, Schwab RJ. State-related changes in upper airway caliber and surrounding soft-tissue structures in normal subjects. Am J Respir Crit Care Med. 1998;158(4):1259–70.
Nayak KS, Fleck RJ. Seeing sleep: dynamic imaging of upper airway collapse and collapsibility in children. IEEE Pulse. 2014;5(5):40–4.
Moon IJ, Han DH, Kim JW, Rhee CS, Sung MW, Park JW, et al. Sleep magnetic resonance imaging as a new diagnostic method in obstructive sleep apnea syndrome. Laryngoscope. 2010;120(12):2546–54.
Donnelly LF, Surdulescu V, Chini BA, Casper KA, Poe SA, Amin RS. Upper airway motion depicted at cine MR imaging performed during sleep: comparison between young patients with and those without obstructive sleep apnea. Radiology. 2003;227(1):239–45.
Darquenne C, Elliott AR, Sibille B, Smales ET, DeYoung PN, Theilmann RJ, et al. Upper airway dynamic imaging during tidal breathing in awake and asleep subjects with obstructive sleep apnea and healthy controls. Physiol Rep. 2018;6(10):e13711.
Kim YC. Fast upper airway magnetic resonance imaging for assessment of speech production and sleep apnea. Precis Fut Med. 2018;2(4):131–48.
Schwab RJ, Pack AI, Gupta KB, Metzger LJ, Oh E, Getsy JE, et al. Upper airway and soft tissue structural changes induced by CPAP in normal subjects. Am J Respir Crit Care Med. 1996;154(4 Pt 1):1106–16.
Wang SH, Keenan BT, Wiemken A, Zang Y, Staley B, Sarwer DB, et al. Effect of weight loss on upper airway anatomy and the apnea-hypopnea index. The importance of tongue fat. Am J Respir Crit Care Med. 2020;201(6):718–27.
Sutherland K, Cistulli PA. Oral appliance therapy for obstructive sleep apnoea: state of the art. J Clin Med. 2019;8(12):2121.
Phillips CL, Grunstein RR, Darendeliler MA, Mihailidou AS, Srinivasan VK, Yee BJ, et al. Health outcomes of continuous positive airway pressure versus oral appliance treatment for obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med. 2013;187(8):879–87.
Chan ASL, Sutherland K, Schwab RJ, Zeng B, Petocz P, Lee RWW, Darendeliler M, Cistulli PA. The effect of mandibular advancement on upper airway structure in obstructive sleep apnoea. Thorax. 2010;65(8):726–32.
Vicini C, Dallan I, Canzi P, Frassineti S, Nacci A, Seccia V, et al. Transoral robotic surgery of the tongue base in obstructive sleep apnea-hypopnea syndrome: anatomic considerations and clinical experience. Head Neck. 2012;34(1):15–22.
Friedman M, Hamilton C, Samuelson CG, Kelley K, Taylor D, Pearson-Chauhan K, et al. Transoral robotic glossectomy for the treatment of obstructive sleep apnea-hypopnea syndrome. Otolaryngol Head Neck Surg. 2012;146(5):854–62.
Lin HS, Rowley JA, Badr MS, Folbe AJ, Yoo GH, Victor L, et al. Transoral robotic surgery for treatment of obstructive sleep apnea-hypopnea syndrome. Laryngoscope. 2013;123(7):1811–6.
Chiffer RC, Schwab RJ, Keenan BT, Borek RC, Thaler ER. Volumetric MRI analysis pre- and post-transoral robotic surgery for obstructive sleep apnea. Laryngoscope. 2015;125(8):1988–95.
Strollo PJ Jr, Soose RJ, Maurer JT, de Vries N, Cornelius J, Froymovich O, for the STAR Trial Group, et al. Upper-airway stimulation for obstructive sleep apnea. N Engl J Med. 2014;370(2):139–49.
Schwab RJ, Wang SH, Verbraecken J, Vanderveken OM, Van de Heyning P, Vos WG, et al. Anatomic predictors of response and mechanism of action of upper airway stimulation therapy in patients with obstructive sleep apnea. Sleep. 2018;41(4):zsy021.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Schwab, R.J., Wiemken, A. (2023). Upper Airway Radiology. In: Thomas, R.J., Bhat, S., Chokroverty, S. (eds) Atlas of Sleep Medicine. Springer, Cham. https://doi.org/10.1007/978-3-031-34625-5_9
Download citation
DOI: https://doi.org/10.1007/978-3-031-34625-5_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-34624-8
Online ISBN: 978-3-031-34625-5
eBook Packages: MedicineMedicine (R0)